Maze Therapeutics, Inc.
MAZE
$7.83
$0.233.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 574.98% | -- | -- | 75.21% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -1.88% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 491.24% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 491.24% | -- | -- | -- | |
| Net Property, Plant & Equipment | -14.48% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 271.49% | -- | -- | -- | |
| Total Assets | 236.40% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | -3.96% | -- | -- | -- | |
| Total Accrued Expenses | 43.78% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 3.19% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 26.70% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 26.70% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -12.21% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -28.99% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 116.34% | -- | -- | -- | |
| Retained Earnings | 9.42% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 16.76% | -- | -- | 7.11% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 32.35% | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 32.35% | -- | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 16.76% | -- | -- | 7.11% | |
| Total Preferred Equity | 32.35% | -- | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 1,858.46% | -- | -- | 19.80% | |
|
|
|||||